Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Anemia

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    855 result(s) found for: Anemia. Displaying page 1 of 43.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2009-014016-35 Sponsor Protocol Number: 2008/258 Start Date*: 2009-09-17
    Sponsor Name:Afdeling V, Aarhus Sygehus
    Full Title: Jernsubstitution efter øvre mavetarmblødning Undersøgelse af effekten af jernbehandling peroralt (Ferro Duretter® ) eller Intravenøst (Ferinject®) i 3 måneder efter udskrivelse versus ingen jernbe...
    Medical condition: Patienter, der har haft akut øvre gastrointestinal blødning med efterfølgende endoskopisk intervention og har nedsat hæmoglobinniveau (mindre end nedre referenceinterval værdi) ved udskrivelsestids...
    Disease: Version SOC Term Classification Code Term Level
    12.0 10002062 Anaemia iron deficiency LLT
    12.0 10002034 Anaemia PT
    12.0 10048861 Anaemia postoperative PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2015-002496-26 Sponsor Protocol Number: ST10-01-304 Start Date*: 2015-12-02
    Sponsor Name:Shield TX (UK) Ltd.
    Full Title: A phase 3b, randomized, controlled, multicentre study with oral ferric maltol (Feraccru) or intravenous iron (ferric carboxymaltose; FCM), for the treatment of iron deficiency anaemia in subjects w...
    Medical condition: Iron deficiency anaemia with inflammatory bowel disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 10005329 - Blood and lymphatic system disorders 10002062 Anaemia iron deficiency LLT
    20.0 10005329 - Blood and lymphatic system disorders 10022972 Iron deficiency anaemia PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) BE (Completed) ES (Completed) HU (Completed)
    Trial results: View results
    EudraCT Number: 2010-023589-39 Sponsor Protocol Number: ST10-01-302 Start Date*: 2012-04-10
    Sponsor Name:Iron Therapeutics (Switzerland) AG
    Full Title: A prospective, multicentre, randomised, double-blind, placebo controlled study with oral ST10-021 for the treatment of iron deficiency anaemia in subjects with quiescent Crohn's Disease where oral ...
    Medical condition: Iron deficiency anaemia in quiescent Crohn's Disease
    Disease: Version SOC Term Classification Code Term Level
    17.0 10005329 - Blood and lymphatic system disorders 10002062 Anaemia iron deficiency LLT
    17.0 10005329 - Blood and lymphatic system disorders 10022972 Iron deficiency anaemia PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) AT (Completed) GB (Completed) HU (Completed)
    Trial results: View results
    EudraCT Number: 2010-023588-16 Sponsor Protocol Number: ST10-01-301 Start Date*: 2012-04-10
    Sponsor Name:Iron Therapeutics (Switzerland) AG
    Full Title: A prospective, multicentre, randomised, double-blind, placebo controlled study with oral ST10-021 for the treatment of iron deficiency anaemia in subjects with quiescent ulcerative colitis where or...
    Medical condition: Iron deficiency anaemia in quiescent ulcerative colitis
    Disease: Version SOC Term Classification Code Term Level
    17.0 10005329 - Blood and lymphatic system disorders 10002062 Anaemia iron deficiency LLT
    17.0 10005329 - Blood and lymphatic system disorders 10022972 Iron deficiency anaemia PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) GB (Completed) AT (Completed) HU (Completed)
    Trial results: View results
    EudraCT Number: 2014-004380-20 Sponsor Protocol Number: SP0986 Start Date*: 2015-02-10
    Sponsor Name:Sanol GmbH
    Full Title: A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulp...
    Medical condition: Iron Deficiency Anemia
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004851 10022974 Iron deficiency anemia LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2014-004232-19 Sponsor Protocol Number: 1VIT13036 Start Date*: 2015-01-29
    Sponsor Name:Luitpold Pharmaceuticals, Inc.
    Full Title: A Multi-center, Open-label, Single Arm Study to Characterize the Pharmacokinetics and Pharmacodynamics Profile of Intravenous Ferric Carboxymaltose in Pediatric Subjects 1 –17 years old with Iron D...
    Medical condition: Iron Deficiency Anemia (IDA)
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004851 10022974 Iron deficiency anemia LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: PL (Completed)
    Trial results: View results
    EudraCT Number: 2009-016847-20 Sponsor Protocol Number: FERRO Start Date*: 2010-01-22
    Sponsor Name:FUNDACION PARA LA INVESTIGACIÓN LA FE
    Full Title: Optimización del tratamiento de la anemia ferropénica secundaria a hemorragia digestiva aguda. Comparación de dos estrategias (hierro intravenoso vs oral).
    Medical condition: Anemia ferropénica susceptible de ser tratada con preparados de hierro, tras hemorragia digestiva aguda.
    Disease: Version SOC Term Classification Code Term Level
    9 10002295 Anemia iron deficiency LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-010623-64 Sponsor Protocol Number: RPV-0802 Start Date*: 2009-04-02
    Sponsor Name:Renapharma AB
    Full Title: A clinical open, randomised study of oral iron (Duroferon®) vs. intravenous iron (Ferinject®) for iron substitution in blood donors.
    Medical condition: Iron deficiency.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10022972 Iron deficiency anaemia LLT
    9.1 10022975 Iron deficiency anemia secondary to blood loss (chronic) LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2020-001389-12 Sponsor Protocol Number: PICS1.0 Start Date*: 2020-10-29
    Sponsor Name:Aarhus University Hospital
    Full Title: The Postoperative Iron in Cardiac Surgery (PICS-) trial: A randomised clinical trial comparing the efficacy of single-, high-dose intravenous iron and oral iron for the treatment of anaemia followi...
    Medical condition: Anaemia following cardiac surgery
    Disease: Version SOC Term Classification Code Term Level
    22.0 100000004851 10057220 Acute post haemorrhagic anaemia LLT
    20.0 100000004851 10022974 Iron deficiency anemia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-005169-21 Sponsor Protocol Number: VEN01URO Start Date*: 2007-06-13
    Sponsor Name:J. Uriach y Compañia, S. A.
    Full Title: Estudio piloto del uso del hierro endovenoso en el postoperatorio de cirugía mayor urológica
    Medical condition: Niveles de hemoglobina en el postoperatorio de cirugía mayor urológica
    Disease: Version SOC Term Classification Code Term Level
    8.1 10002295 Anemia iron deficiency LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-001123-39 Sponsor Protocol Number: SWB0113 Start Date*: 2013-06-21
    Sponsor Name:SerumWerk Bernburg AG
    Full Title: An open label study on safety and pharmacokinetics of an intravenous administered single dose of Feramyl 200 mg in healthy blood donors compared to a single dose of Feramyl 1000 mg in IBD patients...
    Medical condition: Healthy blood donors and anemic patients with inflammatory bowel disease
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004851 10002295 Anemia iron deficiency LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2010-023790-19 Sponsor Protocol Number: Monofer-ISS-Blooddonor-01 Start Date*: 2011-08-29
    Sponsor Name:Rigshospitalet, afd. 2034
    Full Title: Et randomiseret, prospektivt, dobbeltblindt, komparativt, placebokontrolleret forsøg med intravenøs indgift af jernisomaltosid 1000 (Monofer®) via infusioner til bloddonorer med jernmangel
    Medical condition: Forsøg med intravenøs indgift af jernisomaltosid 1000 (Monofer®) via infusioner til bloddonorer med jernmangel. Dobbelblindet, placebokontrolleret forsøg.
    Disease: Version SOC Term Classification Code Term Level
    14.0 10005329 - Blood and lymphatic system disorders 10022974 Iron deficiency anemia LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-004139-49 Sponsor Protocol Number: V00355 CP301 3A Start Date*: 2008-02-05
    Sponsor Name:PIERRE FABRE MEDICAMENT
    Full Title: Efficacy and tolerability of 12-weeks oral treatment with V0355CP3A versus Ferrograd, in iron deficiency anaemia. Multicenter, randomised, open-label trial.
    Medical condition: Iron deficiency anaemia.
    Disease: Version SOC Term Classification Code Term Level
    6.1 10022972 PT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2006-005407-33 Sponsor Protocol Number: KCL/CG02/2006 Start Date*: 2006-11-08
    Sponsor Name:King's College London
    Full Title: The effect of long-term iron treatment on serum NTBI and plasma isoprostanes in anaemic women versus an anaemic control group
    Medical condition: Iron deficiency anaemia, defined as haemoglobin level <12 g/dl, mean cell volume <90 fl, serum ferritin <20 ug/l.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10022972 Iron deficiency anaemia LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-001517-41 Sponsor Protocol Number: VIT-FOLFILM-07 Start Date*: 2007-12-17
    Sponsor Name:Vifor (International) Inc.
    Full Title: Comparative study of the efficacy and tolerability of iron polymaltose complex film-coated tablets with folic acid (Maltofer® Fol film-coated tablets) compared to a generic iron sulphate product in...
    Medical condition: Iron deficiency among pregnant women.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10022972 Iron deficiency anaemia LLT
    Population Age: Adults Gender: Female
    Trial protocol: EE (Prematurely Ended) LV (Prematurely Ended) LT (Prematurely Ended) BG (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2016-004439-19 Sponsor Protocol Number: 16/0099 Start Date*: 2017-06-01
    Sponsor Name:Alfred Health
    Full Title: IV iron for Treatment of Anaemia before Cardiac Surgery
    Medical condition: Anaemia
    Disease: Version SOC Term Classification Code Term Level
    20.0 10005329 - Blood and lymphatic system disorders 10022972 Iron deficiency anaemia PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2005-004737-17 Sponsor Protocol Number: DARB-MDS Start Date*: Information not available in EudraCT
    Sponsor Name:AZIENDA OSPEDALIERA BIANCHI-MELACRINO-MORELLI
    Full Title: Evaluation of the Efficacy of Darbepoetin Alfa for the Treatment of Anemia in Patients with Myelodysplastic Syndrome
    Medical condition: Anemia in patients with myelodysplastic syndrome.
    Disease: Version SOC Term Classification Code Term Level
    6.1 10038269 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-004225-22 Sponsor Protocol Number: CSEG101A2401B Start Date*: 2021-05-03
    Sponsor Name:Novartis Pharma AG
    Full Title: An Open-label, Multi-center, Phase IV, Rollover Study for Patients with Sickle Cell Disease who have Completed a Prior Novartis-Sponsored Crizanlizumab Study
    Medical condition: Sickle Cell Disease
    Disease: Version SOC Term Classification Code Term Level
    21.0 10010331 - Congenital, familial and genetic disorders 10040644 Sickle cell disease PT
    20.1 10010331 - Congenital, familial and genetic disorders 10002077 Anaemia sickle cell LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: BE (Trial now transitioned) DE (Trial now transitioned) ES (Ongoing) IT (Ongoing) FR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2016-005100-26 Sponsor Protocol Number: ORION-PH-1 Start Date*: 2017-10-09
    Sponsor Name:Hannover Medical School
    Full Title: A pilot Study to explore safety, tolerability and efficacy of ORal IrON supplementation with ferric maltol in treating iron deficiency in patients with pulmonary hypertension and iron deficiency an...
    Medical condition: Patients with iron deficiency anemia and pulmonary hypertension
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004851 10022974 Iron deficiency anemia LLT
    20.0 100000004855 10037401 Pulmonary hypertensions HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2018-004304-19 Sponsor Protocol Number: AMAG-FER-IDA-352 Start Date*: 2019-07-10
    Sponsor Name:AMAG Pharmaceuticals, Inc.
    Full Title: A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
    Medical condition: Iron Deficiency Anemia (IDA) in Pediatric Subjects
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004851 10022974 Iron deficiency anemia LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: LT (Ongoing) PL (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 19 16:43:13 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA